FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ:BMTI) today reported its financial results as of and for the three and twelve months ended December 31, 2006. For the three months ended December 31, 2006, the Company reported a net loss of $5.3 million or $(0.34) per share, compared to a net loss of $9.2 million, or $(5.82) per share, for the same period in 2005. For the full year, the Company reported a net loss of $17.2 million, or $(1.62) per share, compared to a net loss of $12.0 million, or $(7.59) per share, for 2005. The Company ended the year in a strong financial position, with $48.1 million of cash and cash equivalents. In February 2007, the Company completed a secondary public offering which provided net proceeds of an additional $40.0 million of cash.
